Drug Ther Bull. 2007 May;45(5):37-40. doi: 10.1136/dtb.2007.45537.
In 2001, we concluded that methylphenidate or dexamfetamine can be useful adjunctive therapy for children with severe hyperactivity in whom non-drug approaches alone have been inadequate. Since then, atomoxetine (pronounced a-toe-moks-e-teen; Strattera - Lilly) and three modified-release formulations of methylphenidate have been launched for attention deficit hyperactivity disorder (ADHD). Here we reconsider drugs for ADHD in childhood, focusing on the newer products.
2001年,我们得出结论,对于仅采用非药物方法治疗效果不佳的重症多动儿童,哌甲酯或右旋苯丙胺可作为有效的辅助治疗药物。自那时起,托莫西汀(发音为a-toe-moks-e-teen;商品名择思达 - 礼来公司生产)以及三种哌甲酯缓释制剂已投放市场用于治疗注意缺陷多动障碍(ADHD)。在此,我们重新审视儿童ADHD的治疗药物,重点关注较新的产品。